5:20 PM
 | 
Aug 27, 2008
 |  BC Extra  |  Clinical News

NexMed down on NM100060 update

NexMed (NASDAQ:NEXM) fell $1.11 (82%) to $0.25 on Wednesday after reporting late Tuesday that partner Novartis (NYSE:NVS; SWX:NOVN) will not submit an NDA to...

Read the full 108 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >